802
Participants
Start Date
May 30, 2017
Primary Completion Date
August 7, 2018
Study Completion Date
October 10, 2019
Tralokinumab
Tralokinumab is a human recombinant monoclonal antibody of the IgG4 subclass that specifically binds to human IL-13 and blocks interaction with the IL-13 receptors. It is presented as a liquid formulation for subcutaneous (SC) administration
Placebo
Placebo contains the same excipients, in the same concentration only lacking tralokinumab
Weil Cornell Medicine, New York
Juva Skin & Laser Center, New York
University at Buffalo Department of Dermatology, Buffalo
UPMC Department of Dermatology, Pittsburgh
The GWU Medical Faculty Associates, Washington D.C.
DermAssociates, PC, Rockville
Virginia Clinical Research, Norfolk
West Virginia Research Institute, Morgantown
Deramatology Consulting Services, PLLC, High Point
Hautärzte Zentrum Hannover, Hannover
Dermatologic Surgery Specialists, Macon
Meridian Clinical Research, Savannah
Georgia Pollens Clinical Research Centers, Inc., Albany
Allergy Center at Brookstone Research, Columbus
Park Avenue Dermatology, Orange Park
Research Institute of the Southeast, LLC, West Palm Beach
ACRC Dermatology, West Palm Beach
Skin Care Research, Inc., Boca Raton
Forward Clinical Trials, Tampa
Clinical Research Center of Alabama, Birmingham
Skin Sciences, PLLC, Louisville
Dermatologists of Greater Columbus, Bexley
University Hospitals Cleveland Medical Center, Cleveland
Deaconess Clinic, Evansville
Derm Center, Troy
Clarkston Skin Research, Clarkston
Altman Dermatology Associates, Arlington Heights
PMG Research of Christie Clinic, Chicago
MediSearch LLC, Saint Joseph
GHRMSA, Service de Dermatologie, Mulhouse
Clinical Trials of SWLA, LLC, Lake Charles
Dermtology Treatment and Research Center, Dallas
Houston Skin Associates, Houston
Center for Clinical Studies, Webster
Austin Dermatology Associates, Austin
Tekton Research, Austin
JDR Dermatology Research, Las Vegas
Dermatology Research Associates, Los Angeles
Quest Dermatology Research, Northridge
Dermatology Specialists, Inc., Oceanside
University Clinical Trials, Inc., San Diego
Tien Q. Nguyen, MD, Inc., Fountain Valley
Center for Dermatology and Laser Surgery, Sacramento
Oregon Medical Research Center, Portland
Oregon Health & Sciences University, Portland
Dermatology Associates of Seattle, Seattle
Centre Hospitalier de Valence, Valence
Hôpital St ANDRE, CHU de BORDEAUX, Service de Dermatologie, Bordeaux
CHRU de Brest - Hôpital Morvan, Service de Dermatologie, Brest
CHU de Dijon, Service de Dermatologie, Dijon
Hôpital Claude Huriez-CHRU, Service de dermatologie, Lille
Hôpital Saint vincent de paul, Clinique de Dermatologie, Lille
Cabinet Médical, Le Bateau Blanc-Immeuble A, Martigues
Centre Hospitalier Universitaire, Clinique dermatologique 7 eme nord, Nantes
Hôpital de l'Archet II, Service de Dermatologie- Vénérologie, Nice
Hôpital Robert Debré, Service de Dermatologie, Reims
Hôpital Charles Nicolle, Clinique Dermatologique, Rouen
C.H.U. de Saint-Etienne - Hôpital Nord, Service de dermatologie, Saint-Etienne
CHU de Toulouse Hôpital Larrey, Service de Dermatologie, Toulouse
Derma-Study-Center Friedrichshafen GmbH, Friedrichshafen
Klinikum Augsburg, Klinik für Dermatologie und Allergologie, Augsburg
Universitätsklinikum Erlangen, Hautklinik, Erlangen
LMU München, Klinik und Poliklinik für Dermatologie und Allergologie, München
Facharztpraxis für Dermatologie, Allergologie, Venerologie und Umweltmedizin, Mahlow
Klinikum Darmstadt GmbH, Hautklinik, Darmstadt
Medizinische Hochschule Hannover, Klinik für Dermatologie, Allergologie und Venerologie, Hannover
KliFOs - Klinische Forschung Osnabrück, Osnabrück
Klinikum Bielefeld Rosenhöhe, Hautklinik, Bielefeld
Niesmann, Hautzentrum im Jahrhunderthaus, Bochum
Universitätsklinikum Bonn, Klinik und Poliklinik für Dermatologie und Allergologie, Bonn
Hautzentrum Dülmen, Dülmen
Universitätsklinikum Essen (AöR), Klinik für Dermatologie, Venerologie und Allergologie, Essen
Universitätsklinikum Münster Klinik und Poliklinik für Hautkrankheiten Münster, Zentrale Studienkoordination für innovative Dermatologie, Münster
Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Dermatologie, Dresden
Universitätsklinikum Leipzig, Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Leipzig
Universitätsklinikum Halle (Saale), Universitätsklinik und Poliklinik für Dermatologie und Venerologie, Halle
SRH Wald-Klinikum Gera, Klinik für klinische Studien, Gera
Charité - Universitätsmedizin Berlin, Klinik für Dermatologie, Allergologie und Venerologie, Berlin
CMB Collegium Medicum Berlin GmbH, Berlin
SCIderm GmbH, Hamburg
Takagi Dermatological Clinic, Obihiro
Hospital Reina Sofía, Servicio Dermatología, Córdoba
Hospital Virgen de la Macarena, Servicio Dermatología, Seville
Hospital de Basurto, Servicio Dermatología, Bilbao
Hospital de Cruces, Servicio Dermatología, Bilbao
Hospital Germans Trias i Pujol, Servicio Dermatología, Badalona
Hospital Clinic de Barcelona, Dermatology Department, Barcelona
Hospital de la Santa Creu i Sant Pau, Servicio Dermatología, Barcelona
Hospital del Mar, Servicio Dermatología, Barcelona
Clínica Universitaria de Navarra, Servicio Dermatología, Pamplona
Hospital de Fuenlabrada, Servicio Dermatología, Madrid
Hospital Infanta Leonor, Servicio Dermatología, Madrid
Hospital Universitario de la Princesa, Servicio Dermatología, Madrid
Hospital Universitario La Paz, Servicio Dermatología, Madrid
Hospital Universitario y Politécnico La Fe, Servicio Dermatología, Valencia
Meiwa Hospital, Hyōgo
Hyogo College Of Medicine Hospital, Hyōgo
KUME Clinic, Sakai
NTT Medical Center Tokyo, Tokyo
Asahikawa City Hospital, Asahikawa
JR Sapporo Hospital, Chūō
Medical Corporation Kojinkai, Chūō
Fukuoka University Hospital, Fukuoka
Kurume University Hospital, Fukuoka
Fukushima Medical University Hospital, Fukushima
Gifu University Hospital, Gifu
Osaka Habikono Medical Center, Habikino
Hamamatsu University hospital, Hamamatsu
Ichinomiya Municipal Hospital, Ichinomiya
Kagoshima University Hospital, Kagoshima
Kyoto Prefectural Hospital, Kyoto
Iwate Prefectural Central Hospital, Morioka
Chukyo Hospital, Nagoya
Gokeikai Osaka Kaisei Hospital, Ōsaka
Osaka Hospital, Ōsaka
Jichi Medical University Hospital, Tochigi
Tokyo Teishin Hospital, Tokyo
The Jikei University Hospital, Tokyo
Nippon Medical School Hospital, Tokyo
The Fraternity Memorial Hospital, Tokyo
Tokyo Medical University Hospital, Tokyo
Ogikubo Hospital, Tokyo
Shirasaki Dermatology Clinic, Tōyama
Lead Sponsor
LEO Pharma
INDUSTRY